#GBA1
Seed amplification analysis of released a-synuclein strains from #Parkinsons-patient derived neurons (iPD, GBA1 N370S, LRRK2 G2019S & SNCA A53T) reveals genotype-specific cellular responses differentially shape the structural properties of released α-syn
www.frontiersin.org/journals/agi...
September 25, 2026 at 9:02 AM
New review summarizes the current understanding of the biological mechanisms linking GBA1 to #Parkinsons, including both loss-of-function & gain-of-function hypotheses; Also clinical & translational advances
academic.oup.com/brain/advanc...
September 23, 2026 at 2:44 AM
まあGBA1作目以降に続くソードマスターの懲役よりはマシ感あるけど……
September 18, 2026 at 4:55 PM
⚖️ COEXPHAL insiste en la revisión del Acuerdo UE-Marruecos para garantizar una competencia leal y proteger la producción hortofrutícola europea 🇪🇺👇

shre.ink/GBa1
COEXPHAL insiste en la revisión del Acuerdo UE-Marruecos para garantizar una competencia leal y proteger la producción hortofrutícola europea
(También nos puedes seguir por nuestro canal de WhatsApp) La Asociación de Organizaciones de Productores de Frutas y Hortalizas de Almería (COEXPHAL) ha reiterado la necesidad de que la Unión Europea ...
shre.ink
September 17, 2026 at 9:52 AM
Today's UGI seminar was from Prof Nikolas Maniatis on dissecting complex inheritance at fine-scale resolution focusing on the GBA1 locus, a risk factor for Parkinson's Disease.

More in the preprint here 👉 www.biorxiv.org/content/10.6....
September 15, 2026 at 8:27 PM
GBAviewer: a structural database of GBA1 variants in Parkinson's disease #NeuroDegeneration 🧪🧠
https://www.biorxiv.org/content/10.64898/2026.09.05.749596v1
September 12, 2026 at 7:01 AM
GBAviewer: a structural database of GBA1 variants in Parkinson's disease https://www.biorxiv.org/content/10.64898/2026.09.05.749596v1
September 12, 2026 at 4:15 AM
GBAviewer: a structural database of GBA1 variants in Parkinson's disease https://www.biorxiv.org/content/10.64898/2026.09.05.749596v1
September 12, 2026 at 4:15 AM
Beyond Parkinson’s disease: expanding the neurodegenerative spectrum of GBA1- associated disorders #NeuroDegeneration 🧪🧠
https://www.researchsquare.com/article/rs-10567488/latest
August 26, 2026 at 1:03 AM
New study "suggests a subtle shift toward a more pro-inflammatory gut microbial profile in GBA1+ #Parkinsons participants, characterized by fewer butyrate-producing & more pro-inflammatory bacteria" (20 PD+GBA1− & 16 PD+GBA1+)
movementdisorders.onlinelibrary.wiley.com/doi/10.1002/...
August 23, 2026 at 11:59 AM
Researchers report biochemical alterations in GCase function are linked to GBA1 mutations independent of #Parkinsons status; “Severe” mutations impact lysosomal function & other processes; HexSph level in blood sig. diff. between GBA1-PD & GBA1-carriers
link.springer.com/article/10.1...
Glucocerebrosidase dysfunction in GBA1 carriers: insights from blood and macrophage analyses - Molecular Biology Reports
Background Mutations in the GBA1 gene, which encodes the lysosomal enzyme glucocerebrosidase (GCase), are the most common genetic factor associated with Parkinson’s disease (PD). These mutations are c...
link.springer.com
August 23, 2026 at 11:13 AM
"Mapping the short reads of 57,630 Icelanders to HPRC-ICE enabled the discovery of pathogenic variants that were camouflaged in segmental duplications. We identified a previously undetected GBA1 variant association to early-onset #Parkinsons in Iceland & in the UK Biobank"
August 21, 2026 at 3:55 PM
They "uncovered new variants in low-mappability regions, including a pathogenic single nucleotide polymorphism in GBA1 that associates with early onset #Parkinsons" & they replicated the GBA1 association in the UK Biobank of 429,193 British & Irish participants
August 21, 2026 at 3:55 PM
This case highlights a patient with EOPD carrying two major genetic risk factors: a 22q11.2 microdeletion and a pathogenic GBA1 mutation. The authors propose that cumulative genetic burden may help explain an onset far earlier than expected for either variant alone. https://loom.ly/m_J26RE
August 21, 2026 at 3:07 PM
A global brain bank study found that misdiagnosis and Alzheimer’s disease copathology were common. GBA1 and LRRK2 variants were also associated with different levels of Lewy body pathology.

🔗 Read the #publication: bit.ly/4bwaPVh
August 20, 2026 at 3:03 PM
Using data from more than 25,000 people with Parkinson’s, researchers found that limiting genetic testing to people with an age at onset of 50 or younger may miss many LRRK2 and GBA1 variant carriers.

🔗 Read the #publication: bit.ly/4xlgA0n
August 20, 2026 at 3:03 PM
We uncovered p.Leu483Pro in GBA1 (AF=0.22%), a missense variant not found in our Icelandic BWA-MEM set or in the UK Biobank. The allele was present in two of the ICE haplotypes but not in the HPRC haplotypes. p.Leu483Pro associated with Parkinson’s disease with p=2.94x10-6 and OR=2.55. (5/7)
August 20, 2026 at 9:11 AM
Just submitted a Parkinson’s Disease LOI looking at the intersection of TDP-43 pathology and synuclein/GBA1 using our new inducible models of TDP-43 Neurodegeneration!

I have never worked with PD, but I have close family history with the disease, and am very excited!
Wolf Of Wall Street: Lets Gooo!
ALT: Wolf Of Wall Street: Lets Gooo!
static.klipy.com
August 18, 2026 at 2:56 PM
Check out iSCORE-PD: 65 edited hPSC lines for PD, covering 11 genes, all from 1 hESC … PMID:42310027, Nat Commun 2026, @NatureComms @OTSociety @NAR_Open https://doi.org/10.1038/s41467-026-74355-8 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
iSCORE-PD: an isogenic stem cell collection to research Parkinson’s disease | Nature Communications
Genome-edited human pluripotent stem cells (hPSCs) provide a powerful platform to study complex diseases such as Parkinson’s disease (PD). Here, we describe iSCORE-PD, an isogenic collection of 65 genome-edited hPSC lines carrying disease-causing or high-risk variants in 11 PD-linked genes (SNCA, PRKN, PINK1, DJ1/PARK7, LRRK2, ATP13A2, FBXO7, DNAJC6, SYNJ1, VPS13C, and GBA1). All lines are derived from a well-characterized female hESC line and subjected to extensive quality control. Whole-genome sequencing reveals that genetic variation between lines, largely confined to non-coding regions, is minimal relative to inter-individual differences in patient-derived hiPSCs, with most variation arising from random mutations acquired during cell culture rather than genome-editing-induced off-target effects. Including multiple independently derived clones per mutation can control for this random genetic drift. Our systematic approach ensures high quality of this publicly available iSCORE-PD res
doi.org
August 16, 2026 at 2:00 PM
They synthesized 8 variants of all 16 isomers of 1-deoxynojirimycin and evaluated them for binding to glucosylceramide synthase (GCS), lysosomal glucosylceramidase (GBA1), and nonlysosomal glucosylceramidase (GBA2). (2/2)

#ChemSky #ChemBio #GlycoTime
August 15, 2026 at 1:01 PM
ICYMI in our August issue: Parkinson's disease genetic variants across ancestrally diverse populations, in a multi-ancestry cross-sectional genetic study of data from the Global Parkinson's Genetics Program (GP2) www.thelancet.com/journals/lan...
Parkinson's disease genetics across diverse ancestries: an observational genetic study of causal and risk variants with translational implications
This large-scale, multi-ancestry genetic study offers crucial insights into the population-specific genetic architecture of Parkinson's disease. Whereas clinical trials targeting GBA1 and LRRK2 varian...
www.thelancet.com
August 11, 2026 at 7:45 AM
Quantitative biochemical profiling in post-mortem human brains demonstrates a link between pSer129-enriched α-synuclein deposition & GCase deficiency across the #Parkinsons spectrum, supporting lysosomal/GCase-enhancing therapies regardless of GBA1 status
www.nature.com/articles/s41...
August 6, 2026 at 10:26 PM
New review summarizes the current understanding of Gaucher disease & #Parkinsons, with a particular focus on GBA1 variants associated with an increased risk to develop PD; Useful table of clinical trials targeting GBA1
www.nature.com/articles/s41...
August 6, 2026 at 8:22 PM
CRN Team Schapira found that GBA1 variant carriers without Parkinson’s symptoms showed gut microbiome composition partly intermediate between controls and people with Parkinson's, suggesting a potential early marker.

🔗 Read the #publication: bit.ly/4z0lEsO
August 5, 2026 at 3:49 PM
Gaucher 的三個 G
GBA1 基因缺陷 → 缺 Glucocerebrosidase → 堆積 Glucocerebroside。
體染色體隱性遺傳,酵素替代療法是 type I 的標準治療。
Niemann-Pick 才是缺 acid sphingomyelinase、堆積 sphingomyelin —— 兩者最常被對調。
#血液專科
https://hema-2026.hsiehting.com/q/110-034
August 4, 2026 at 6:24 AM